Inferring long QT1 genotype based on a simple epinephrine infusion protocol: From the bedside to the bench and back

Mayo Clinic Proceedings

Volumn 77, Issue 5, 2002, Pages 405-406

  Perry, James C ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN;

DEFIBRILLATION; DIAGNOSTIC TEST; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG SAFETY; EDITORIAL; ELECTROCARDIOGRAM; EXERCISE TEST; GENOTYPE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; HUMAN; INTENSIVE CARE; LONG QT SYNDROME; PROVOCATION TEST; QT INTERVAL;

EID: 0036242156     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)62207-6     Document Type: Editorial

References (8)

1. Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome
2. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
3. Is exercise testing useful in identifying congenital long QT syndrome?
4. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel
5. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
6. Low penetrance in the long-QT syndrome: Clinical impact
7. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy
8. Effects of flecainide in patients with new SCN5A mutation: Mutation-specific therapy for long-QT syndrome?